CDX2 and pancreatic adenocarcinoma: While CDX2 appears to have somewhat higher sensitivity for CRC than SATB2, the previous studies have indicated that SATB2 has higher specificity for CRC, as CDX2 is frequently also expressed by adenocarcinomas of the pancreas or the upper gastrointestinal tract among others [5, 43].